SCHEMBL16483889

SCHEMBL16483889

c1ccc(-n2c3ccc(-c4cccc5c4oc4ccccc45)cc3c3c4oc5c(ccc6c5c5cc(-c7cccc8c7oc7ccccc78)ccc5n6-c5ccccc5)c4ccc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.50
▸ PRKDC P78527 5/20 0.43
▸ GGPS1 O95749 1/20 0.39
▸ PTGES2 Q9H7Z7 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ BRCA1 P38398 1/20 0.36
▸ PPARG P37231 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ NR2E3 Q9Y5X4 1/20 0.34
▸ NCOR2 Q9Y618 1/20 0.34
▸ PRMT5 O14744 1/20 0.34
▸ WDR77 Q9BQA1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16641317 0.94 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16641316 0.92 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL21116896 0.92 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL15804115 0.91 ALOX5 (0.44) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16648200 0.91 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL21925513 0.91 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16484446 0.91 ALOX5 (0.45) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16484414 0.91 ALOX5 (0.48) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16484385 0.91 ALOX5 (0.44) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL457914 0.90 ALOX5 (0.57) ALOX5PRKDCGGPS1PTGES2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 — — US disclosed
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 — — US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 — — US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 — — US disclosed
WO-2014057684-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME 出光興産株式会社 (JP) 2014-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME YBX1, ATXN2L, ATXN2 ALOX5 1455/4885PRKDC 4771/4885GGPS1 4134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback